VitaNova Life Sciences (VNOV) Return on Invested Capital (2019 - 2022)

VitaNova Life Sciences (VNOV) posted Return on Invested Capital of 0.0% for Q1 2022, up 1.59% on a QoQ basis from 0.0% in Q4 2021, and little changed year-over-year from 0.0% in Q1 2021.

VitaNova Life Sciences (VNOV) Return on Invested Capital (2019 - 2022) Analysis & Trends

VitaNova Life Sciences' Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.0% for Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Mckesson 105.42 Bn 101.44 Bn 4.04 Bn 0.00%
2 Cencora 60.88 Bn 58.70 Bn 3.59 Bn 0.02%
3 Cardinal Health 53.89 Bn 49.95 Bn 2.50 Bn 0.00%
4 Henry Schein 9.80 Bn 9.66 Bn 1.07 Bn 0.00%
5 Akso Health 3.06 Bn 3.06 Bn - -
6 111 651.73 Mn 572.63 Mn 23.58 Mn 0.00%
7 Accendra Health 246.49 Mn -90.39 Mn 278.03 Mn 0.00%
8 Edap Tms 228.64 Mn 213.64 Mn 8.15 Mn -0.01%
9 VitaNova Life Sciences 11.51 Mn 11.01 Mn 316,343.00 -
10 Cosmos Health 9.29 Mn 7.13 Mn 1.38 Mn -0.01%

Historic Data

Download Data
DateValue
Jan 31, 2022 0.00%
Oct 31, 2021 0.00%
Jul 31, 2021 0.00%
Jan 31, 2021 0.00%
Oct 31, 2020 0.00%
Jul 31, 2020 0.00%
Apr 30, 2020 0.00%
Jan 31, 2020 0.00%
Oct 31, 2019 -0.01%
Jul 31, 2019 -0.01%